FDAnews
www.fdanews.com/articles/207238-oxipit-obtains-ce-mark-for-autonomous-ai-medical-imaging-application

Oxipit Obtains CE Mark for Autonomous AI Medical Imaging Application

April 4, 2022

Vilnius, Lithuania-based medical imaging application developer Oxipit has been granted a CE mark for its ChestLink autonomous artificial intelligence (AI) imaging suite.

The ChestLink software can automate up to 40 percent of daily radiology reporting workflow, the company said. The application automatically reports on chest X-rays featuring no abnormalities without any involvement from a radiologist.

The imaging software has already been used in multiple pilot locations for more than a year, processing more than 500,000 real-world chest X-ray images, the company said.

View today's stories